Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
6,200
Employees6,200
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
6,200
Employees6,200

MEDP Key Statistics

Market cap
12.78B
Market cap12.78B
Price-Earnings ratio
29.05
Price-Earnings ratio29.05
Dividend yield
Dividend yield
Average volume
325.59K
Average volume325.59K
High today
$464.93
High today$464.93
Low today
$445.68
Low today$445.68
Open price
$450.33
Open price$450.33
Volume
320.65K
Volume320.65K
52 Week high
$628.92
52 Week high$628.92
52 Week low
$250.05
52 Week low$250.05

Stock Snapshot

With a market cap of 12.78B, Medpace(MEDP) trades at $450.41. The stock has a price-to-earnings ratio of 29.05.

On 2026-03-13, Medpace(MEDP) stock traded between a low of $445.68 and a high of $464.93. Shares are currently priced at $450.41, which is +1.1% above the low and -3.1% below the high.

The Medpace(MEDP)'s current trading volume is 320.65K, compared to an average daily volume of 325.59K.

During the past year, Medpace(MEDP) stock moved between $250.05 at its lowest and $628.92 at its peak.

During the past year, Medpace(MEDP) stock moved between $250.05 at its lowest and $628.92 at its peak.

MEDP News

Simply Wall St 14h
Does Barclays’ AI Reassessment Reframe Medpace as a Higher-Quality, More Durable Growth Story?

Earlier this week, Barclays upgraded Medpace Holdings, arguing that market worries about artificial intelligence disrupting life sciences are overstated and poi...

Does Barclays’ AI Reassessment Reframe Medpace as a Higher-Quality, More Durable Growth Story?
Simply Wall St 2d
A Look At Medpace Holdings Valuation After Recent Share Price Pullback

Advertisement Why Medpace Holdings (MEDP) Is On Investors’ Radar Today Medpace Holdings (MEDP) is drawing fresh attention after a solid period of operational...

A Look At Medpace Holdings Valuation After Recent Share Price Pullback
Nasdaq 4d
Medpace Outpaces Stock Market Gains: What You Should Know

Medpace (MEDP) ended the recent trading session at $389.41, demonstrating a +0.79% swing from the preceding day's closing price. The stock's performance was ahe...

Medpace Outpaces Stock Market Gains: What You Should Know

Analyst ratings

56%

of 16 ratings
Buy
25%
Hold
56.3%
Sell
18.8%

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.